NEW YORK (GenomeWeb News) – TriLink BioTechnologies said today that Nacalai USA will distribute TriLink's nucleic acid products in certain Asian countries.

Under the agreement, Nacalai will distribute TriLink's technologies in Japan, Singapore, South Korea, and Taiwan.

TriLink's product offerings include custom oligonucleotides, modified nucleoside triphosphates, and its CleanAmp PCR products for the diagnostic and OEM markets.

Nacalai USA is the San Diego-based subsidiary of Nacalai Tesque, of Kyoto, Japan.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.